FAKHRAVAC

Vaccine candidate against COVID-19

Texte en anglais

Dernier prix

—

Prix plancher

—

Médiane 7 j

—

Ventes 30 j

Fourchette 30 j

—

En circulation

Cours

Voir le tableau

Date	médiane	Min	Max	ventes

Historique des ventes

Dernière vente: —
Moyenne 30 j: —
Plus bas 30 j: —
Plus haut 30 j: —
Ventes 7 j: 0
Ventes 30 j: 0

Aucune vente pour l'instant.

Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.

Sur Wikipédia

Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.

FAKHRAVAC (Persian: واکسن فخرا) is a COVID-19 vaccine developed in Iran by the Organization of Defensive Innovation and Research, a subsidiary of Iran's Ministry of Defense. It is the third Iranian COVID-19 vaccine reaching clinical trials. It is currently in phase III. It received emergency use authorization in Iran on 9 September 2021. The vaccine is named after the Iranian nuclear scientist Mohsen Fakhrizadeh. According to the Iranian authorities, he was working on a vaccine in response to the COVID-19 pandemic in Iran. Fakhrizadeh was assassinated in November 2020 in an attack Iran and US intelligence attributed to Israel.

Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : Shared by Fars News Agency (CC BY 4.0) ·